A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.
Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of A 001 infusion in preventing
acute chest syndrome in sickle cell disease (SCD) subjects with vaso-occlusive crisis, fever,
and elevated serum C-reactive protein (CRP).